Investors sold shares of Johnson & Johnson (NYSE:JNJ) on strength during trading on Wednesday. $85.32 million flowed into the stock on the tick-up and $245.88 million flowed out of the stock on the tick-down, for a money net flow of $160.56 million out of the stock. Of all companies tracked, Johnson & Johnson had the 3rd highest net out-flow for the day. Johnson & Johnson traded up $1.39 for the day and closed at $141.06

Several equities research analysts recently commented on the stock. J P Morgan Chase & Co lifted their price target on shares of Johnson & Johnson from $140.00 to $148.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 16th. Citigroup assumed coverage on shares of Johnson & Johnson in a research note on Monday, September 25th. They set a “neutral” rating and a $140.00 price target on the stock. Jefferies Group set a $145.00 price target on shares of Johnson & Johnson and gave the stock a “hold” rating in a research note on Tuesday, August 15th. BMO Capital Markets reiterated a “positive” rating and set a $152.00 price target (up from $145.00) on shares of Johnson & Johnson in a research note on Wednesday, October 18th. Finally, Royal Bank Of Canada lifted their price target on shares of Johnson & Johnson from $144.00 to $147.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 18th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and eleven have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $144.59.

The company has a current ratio of 1.32, a quick ratio of 1.02 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $377,720.00, a P/E ratio of 19.47, a P/E/G ratio of 2.83 and a beta of 0.80.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings data on Tuesday, October 17th. The company reported $1.90 EPS for the quarter, beating analysts’ consensus estimates of $1.80 by $0.10. The company had revenue of $19.65 billion for the quarter, compared to analyst estimates of $19.29 billion. Johnson & Johnson had a net margin of 21.28% and a return on equity of 27.38%. Johnson & Johnson’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the business posted $1.68 earnings per share. equities analysts expect that Johnson & Johnson will post 7.28 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Tuesday, November 28th will be paid a $0.84 dividend. The ex-dividend date of this dividend is Monday, November 27th. This represents a $3.36 dividend on an annualized basis and a yield of 2.38%. Johnson & Johnson’s dividend payout ratio is presently 58.33%.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its holdings in shares of Johnson & Johnson by 1.5% in the second quarter. Vanguard Group Inc. now owns 200,450,985 shares of the company’s stock valued at $26,517,661,000 after acquiring an additional 3,023,110 shares in the last quarter. BlackRock Inc. boosted its holdings in shares of Johnson & Johnson by 2.6% in the second quarter. BlackRock Inc. now owns 174,073,764 shares of the company’s stock valued at $23,028,219,000 after acquiring an additional 4,332,612 shares in the last quarter. State Street Corp boosted its holdings in shares of Johnson & Johnson by 4.3% in the first quarter. State Street Corp now owns 160,223,321 shares of the company’s stock valued at $19,955,806,000 after acquiring an additional 6,656,371 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Johnson & Johnson by 0.4% in the third quarter. Bank of New York Mellon Corp now owns 36,594,054 shares of the company’s stock valued at $4,757,593,000 after acquiring an additional 130,437 shares in the last quarter. Finally, FMR LLC boosted its holdings in shares of Johnson & Johnson by 5.9% in the second quarter. FMR LLC now owns 27,237,648 shares of the company’s stock valued at $3,603,268,000 after acquiring an additional 1,509,745 shares in the last quarter. Institutional investors own 65.90% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/12/07/investors-sell-johnson-johnson-jnj-on-strength-jnj.html.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Receive News & Stock Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related stocks with our FREE daily email newsletter.